
无数据
无数据
无数据
| CAS Number | 526-08-9 |
| Catalog Number | AG003UGQ(AGN-PC-0JK77K) |
| Chemical Name | SULFAPHENAZOLE |
| EC Number | 208-384-3 |
| IUPAC Name | 4-amino-N-(2-phenylpyrazol-3-yl)benzenesulfonamide |
| InChI | InChI=1S/C15H14N4O2S/c16-12-6-8-14(9-7-12)22(20,21)18-15-10-11-17-19(15)13-4-2-1-3-5-13/h1-11,18H,16H2 |
| InChI Key | QWCJHSGMANYXCW-UHFFFAOYSA-N |
| MDL Number | MFCD00057226 |
| Molecular Formula | C15H14N4O2S |
| Molecular Weight | 314.3623 |
| NSC Number | 757859 |
| SMILES | NC1=CC=C(C=C1)S(=O)(=O)NC1=CC=NN1C1=CC=CC=C1 |
| UNII | 0J8L4V3F81 |
| Synonyms | Phenylsulfapyrazole,
Sulfaphenazole,
Sulfaphenylpyrazol,
Sulphaphenazole,
sulfaphenazole,
Sulphaphenazole,
526-08-9,
Sulfabid,
Plisulfan,
Raziosulfa,
Sulfafenazol,
Sulfaphenazol,
Sulfaphenazon,
Depocid,
Depotsulfonamide,
Sulphenazole,
Sulfaphenylpyrazole,
Sulfaphenylpipazol,
Sulfafenazolo,
Sulfaphenazolum,
4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide,
Eftolon,
Firmazolo,
Paidazolo,
Inamil,
Isarol,
Merian,
Orisul,
Microtan pirazolo,
1-Phenyl-5-sulfanilamidopyrazole,
5-Sulfanilamido-1-phenylpyrazole,
Sulfaphenylpyrazol,
Phenylsulfapyrazole,
Sulfafenazolo [Italian],
N'-(1-Phenylpyrazol-5-yl)sulfanilamide,
Solfafenazolo,
Sulfafenazol [INN-Spanish],
Sulfaphenazol [INN-French],
Solfafenazolo [DCIT],
Sulfaphenazolum [INN-Latin],
3-(p-Aminobenzenesulfonamido)-2-phenylpyrazole,
Benzenesulfonamide, 4-amino-N-(1-phenyl-1H-pyrazol-5-yl)-,
UNII-0J8L4V3F81,
Orisulf,
N1-(1-Phenylpyrazol-5-yl)sulfanilamide,
Isarol V,
Sulfaphenazole [INN:JAN],
Prestwick_454,
4-amino-N-(2-phenylpyrazol-3-yl)benzenesulfonamide,
C15H14N4O2S,
N(sup 1)-(1-Phenylpyrazol-5-yl)sulfanilamide,
EINECS 208-384-3,
Lopac-S-0758,
Sulfaphenazole (JAN/INN),
BRN 0308518,
CHEMBL1109,
CHEBI:77780,
QWCJHSGMANYXCW-UHFFFAOYSA-N,
0J8L4V3F81,
MFCD00057226,
NCGC00015925-02,
CAS-526-08-9,
N(1)-(1-Phenylpyrazol-5-yl)sulfanilamide,
Sulfanilamide, N1-(1-phenylpyrazol-5-yl)-,
DSSTox_CID_24131,
DSSTox_RID_80106,
DSSTox_GSID_44131,
Sulfanilamide, N(sup 1)-(1-phenylpyrazol-5-yl)-,
4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)-benzenesulfonamide,
4-Amino-N-(2-phenyl-2H-pyrazol-3-yl)-benzenesulfonamide,
Sulfanilamide, N(sup 1)-(1-phenylpyrazol-5-yl)- (8CI),
SMR000326684,
SR-01000075649,
[(4-aminophenyl)sulfonyl](1-phenylpyrazol-5-yl)amine,
Sulfonylpyrazol,
Sulfaphenazole [INN:BAN:JAN],
Sulfabid (TN),
Sulfaphenazole/Sulfabid,
Spectrum_001406,
Prestwick0_000021,
Prestwick1_000021,
Prestwick2_000021,
Prestwick3_000021,
Spectrum2_001943,
Spectrum3_001741,
Spectrum4_000443,
Spectrum5_001185,
Sulfaphenazole, >=98%,
AC1L1K4K,
UC166_SIGMA,
Lopac0_001095,
BSPBio_000081,
BSPBio_003442,
KBioGR_000826,
KBioSS_001886,
5-25-09-00415 (Beilstein Handbook Reference),
MLS000859612,
MLS001056713,
DivK1c_000303,
S0758_SIGMA,
SCHEMBL122040,
SPECTRUM1501143,
SPBio_002002,
SPBio_002005,
BPBio1_000091,
DTXSID2044131,
CTK8G3260,
HMS500P05,
KBio1_000303,
KBio2_001886,
KBio2_004454,
KBio2_007022,
KBio3_002662,
ZINC57490,
NINDS_000303,
HMS1568E03,
HMS1921J13,
HMS2095E03,
HMS2235J21,
HMS3263K12,
HMS3373E16,
HMS3712E03,
Pharmakon1600-01501143,
Sulfaphenazole, >=98% (HPLC),
ALBB-025160,
BCP27626,
HY-B1218,
ZX-AN023674,
Tox21_110262,
Tox21_501095,
ABP000631,
BDBM50090677,
CCG-39431,
NSC757859,
Pyrazole, 1-phenyl-5-sulfanilamido-,
SBB018383,
STK663863,
AKOS003348743,
Tox21_110262_1,
API0025190,
CS-4843,
DB06729,
LP01095,
MCULE-5658431414,
NSC-757859,
IDI1_000303,
NCGC00015925-01,
NCGC00015925-03,
NCGC00015925-04,
NCGC00015925-05,
NCGC00015925-06,
NCGC00015925-07,
NCGC00015925-08,
NCGC00015925-09,
NCGC00015925-10,
NCGC00015925-12,
NCGC00015925-13,
NCGC00094368-01,
NCGC00094368-02,
NCGC00094368-03,
NCGC00094368-04,
NCGC00094368-05,
NCGC00261780-01,
AK405200,
AN-16915,
LS-31277,
SC-66871,
ST078027,
SBI-0051065.P003,
AB2000163,
AB00052218,
EU-0101095,
FT-0761575,
R1865,
Z3406,
BIM-0051065.0001,
D01954,
S 0758,
AB00052218_10,
C-44305,
3-(p-Aminobenzenesulfonamido)-2-pheny-2H-lpyrazole,
SR-01000075649-2,
SR-01000075649-7,
SR-01000075649-8,
SR-01000075649-9,
BRD-K10671814-001-05-6,
BRD-K10671814-001-09-8,
4-amino-N-(1-phenyl-1H-pyrazol-5-yl)-1-benzenesulfonamide,
4-amino-N-(1-phenyl-1H-pyrazol-5-yl)benzene-1-sulfonamide,
D0A4YE,
CID5335,
Sulfaphenazole, 99% - 1G 1g,
C15-H14-N4-O2-S,
CS-T-42785,
D013426,
SP,
SPP,
|
| Complexity | 451 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 314.084g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 22 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 314.363g/mol |
| Monoisotopic Mass | 314.084g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 98.4A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 1.5 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302 |
| Packing Group | |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

